Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessShort paper

Severe combined hyperlipidaemia and retinal lipid infiltration in a patient with Type 2 diabetes mellitus

Rachel A Davey1 email, Niall C Tebbutt2 email, Jenny M Favaloro1 email, David N O'Neal2 email, Derek Rae3 email, Jeffrey D Zajac1 email and James D Best2 email

Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia

Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Victoria, Australia

Department of Pathology, St Vincent's Hospital, Fitzroy, Victoria, Australia

author email corresponding author email

Lipids in Health and Disease 2006, 5:29doi:10.1186/1476-511X-5-29

Published: 17 December 2006

Abstract

Severe combined hyperlipidaemia has occasionally been associated with infiltration of tissues in addition to arteries and the skin. We report a woman with Type 2 diabetes mellitus (DM) and severe combined hyperlipidaemia who developed retinal lipid infiltration, resulting in blindness. A 61-year-old woman with a 15-year history of Type 2 DM was admitted following a two-week history of progressive visual loss. Examination identified lipid infiltration into the retina. Phenotypically she had severe combined hyperlipidaemia with elevated IDL cholesterol and a broad beta band on lipoprotein electrophoresis, raising the possibility of familial dysbetalipoproteinaemia. However, gene sequencing analysis indicated that the patient was homozygous for the E3/E3 allele of the ApoE gene with no mutations detected in either the coding region or intron-exon boundaries. Her lipid profile improved following dietary therapy and gemfibrozil treatment, but this had little effect on either her fundal appearances or her visual acuity. Type 2 DM plays a vital role both in allowing expression of severe combined hyperlipoproteinaemia, in addition to serving as a risk factor for complications such as tissue infiltration.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.